These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24931219)

  • 1. Animal models of invasive aspergillosis for drug discovery.
    Paulussen C; Boulet GA; Cos P; Delputte P; Maes LJ
    Drug Discov Today; 2014 Sep; 19(9):1380-6. PubMed ID: 24931219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence.
    Lionakis MS; Lewis RE; May GS; Wiederhold NP; Albert ND; Halder G; Kontoyiannis DP
    J Infect Dis; 2005 Apr; 191(7):1188-95. PubMed ID: 15747256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillus--classification and antifungal susceptibilities.
    Buzina W
    Curr Pharm Des; 2013; 19(20):3615-28. PubMed ID: 23278534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuances of new anti-Aspergillus antifungals.
    Perfect JR
    Med Mycol; 2005 May; 43 Suppl 1():S271-6. PubMed ID: 16110820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspergillus species intrinsically resistant to antifungal agents.
    Van Der Linden JW; Warris A; Verweij PE
    Med Mycol; 2011 Apr; 49 Suppl 1():S82-9. PubMed ID: 20662634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiologic study of drug-resistant Aspergillus and optimizing newer treatment].
    Izumikawa K
    Jpn J Antibiot; 2011 Feb; 64(1):27-34. PubMed ID: 21612041
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental efficacy of anidulafungin against Aspergillus terreus species complex.
    Sanchis M; Capilla J; Mayayo E; Pastor FJ; Guarro J
    Med Mycol; 2015 Aug; 53(6):630-5. PubMed ID: 25980004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of drug-resistant Aspergillus infection.
    Aigner M; Lass-Flörl C
    Expert Opin Pharmacother; 2015; 16(15):2267-70. PubMed ID: 26328502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia.
    Peláez T; Álvarez-Pérez S; Mellado E; Serrano D; Valerio M; Blanco JL; Garcia ME; Muñoz P; Cuenca-Estrella M; Bouza E
    J Med Microbiol; 2013 Mar; 62(Pt 3):474-478. PubMed ID: 23161769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luliconazole, an alternative antifungal agent against Aspergillus terreus.
    Zargaran M; Taghipour S; Kiasat N; Aboualigalehdari E; Rezaei-Matehkolaei A; Zarei Mahmoudabadi A; Shamsizadeh F
    J Mycol Med; 2017 Sep; 27(3):351-356. PubMed ID: 28483449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drosophila melanogaster as a model organism for invasive aspergillosis.
    Lionakis MS; Kontoyiannis DP
    Methods Mol Biol; 2012; 845():455-68. PubMed ID: 22328395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive aspergillosis: resistance to antifungal drugs.
    Hadrich I; Makni F; Neji S; Abbes S; Cheikhrouhou F; Trabelsi H; Sellami H; Ayadi A
    Mycopathologia; 2012 Aug; 174(2):131-41. PubMed ID: 22327841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fruit flies as a minihost model for studying drug activity and virulence in Aspergillus.
    Lionakis MS; Kontoyiannis DP
    Med Mycol; 2005 May; 43 Suppl 1():S111-4. PubMed ID: 16110801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Antifungal Susceptibility Profile of
    Cho SY; Lee DG; Kim WB; Chun HS; Park C; Myong JP; Park YJ; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer combination antifungal therapies for invasive aspergillosis.
    Steinbach WJ; Juvvadi PR; Fortwendel JR; Rogg LE
    Med Mycol; 2011 Apr; 49 Suppl 1(0 1):S77-81. PubMed ID: 20608784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens.
    Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S
    J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
    Paulussen C; Boulet G; Bosschaerts T; Cos P; Fortin A; Maes L
    Mycoses; 2015 Mar; 58(3):127-32. PubMed ID: 25590577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triazole Antifungal Susceptibility Patterns among
    Cheng MP; Lawandi A; Lee TC; Dufresne PJ; Seidel D; Verweij PE; Cornely OA; Sheppard DC
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30918044
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.
    Glampedakis E; Coste AT; Aruanno M; Bachmann D; Delarze E; Erard V; Lamoth F
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30323034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostics and susceptibility testing in Aspergillus.
    Bernal-Martínez L; Alastruey-Izquierdo A; Cuenca-Estrella M
    Future Microbiol; 2016; 11(2):315-28. PubMed ID: 26848512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.